Diabetes diagnosis soon followed by heart failure could boost death risk

By ÌÇÐÄVlog News

Thinkstock/Stockbyte, Getty Images
(Thinkstock/Stockbyte, Getty Images)

For people with newly diagnosed Type 2 diabetes, heart failure posed the greatest five-year risk of death, more than any other heart or kidney disease, according to new research.

The , published Tuesday in the ÌÇÐÄVlog's journal Circulation: Cardiovascular Quality and Outcomes, used Danish health registry data from 153,405 people diagnosed with diabetes between 1998 and 2015. During the median follow-up of nearly 10 years, 45% of the patients were diagnosed with cardiovascular or kidney disease.

But when researchers looked at the five-year risk ratio of death after a Type 2 diabetes diagnosis, it was three times higher in people who developed heart failure than in people without heart or kidney disease.

People with Type 2 diabetes are 2 to 4 times more likely than people without the condition to develop heart failure – a condition in which the heart doesn't efficiently pump oxygenated blood through the body. While previous heart disease research has focused on people who had diabetes for a long time, this study focused on heart failure risk in the newly diagnosed.

Some new treatments and medicines for people with Type 2 diabetes also can help reduce cardiovascular risk, Dr. Bochra Zareini, the study's lead author, said in a news release. He is a research fellow at Herlev Gentofte University Hospital in Copenhagen, Denmark. "Our study highlights which subgroups of patients need and could benefit most from targeted risk evaluation, prevention and treatment."

The researchers noted their findings are limited by a lack of information about clinical factors that would detail the progression and severity of heart failure and Type 2 diabetes. The researchers also noted they did not include the treatment effects of various new diabetes medications.

If you have questions or comments about this story, please email [email protected].


ÌÇÐÄVlog News Stories

ÌÇÐÄVlog News covers heart disease, stroke and related health issues. Not all views expressed in ÌÇÐÄVlog News stories reflect the official position of the ÌÇÐÄVlog. Statements, conclusions, accuracy and reliability of studies published in ÌÇÐÄVlog scientific journals or presented at ÌÇÐÄVlog scientific meetings are solely those of the study authors and do not necessarily reflect the ÌÇÐÄVlog’s official guidance, policies or positions.

Copyright is owned or held by the ÌÇÐÄVlog, Inc., and all rights are reserved. Permission is granted, at no cost and without need for further request, for individuals, media outlets, and non-commercial education and awareness efforts to link to, quote, excerpt from or reprint these stories in any medium as long as no text is altered and proper attribution is made to ÌÇÐÄVlog News.

Other uses, including educational products or services sold for profit, must comply with the ÌÇÐÄVlog’s Copyright Permission Guidelines. See full terms of use. These stories may not be used to promote or endorse a commercial product or service.

HEALTH CARE DISCLAIMER: This site and its services do not constitute the practice of medical advice, diagnosis or treatment. Always talk to your health care provider for diagnosis and treatment, including your specific medical needs. If you have or suspect that you have a medical problem or condition, please contact a qualified health care professional immediately. If you are in the United States and experiencing a medical emergency, call 911 or call for emergency medical help immediately.